Cart is empty Puerto Rico health officials on Thursday declared an influenza epidemic in the U.S. territory.
U.S. childhood vaccination exemptions reach their highest level ever
The proportion of U.S. kindergartners exempted from school vaccination requirements has hit its highest level ever, 3%, U.S. health officials said Thursday.
Amazon takes another shot at health care, this one a virtual care service that costs $9 per month
Amazon is taking another shot at becoming a regular health care source for customers with the launch of a service centered on virtual care.
Concurrent RNA and DNA sequencing improves variant detection
Performing RNA sequencing concurrently with DNA sequencing improves detection of novel variants and classification of existing variants, according to a study published online Nov. 4 in JAMA Oncology to coincide with the annual meeting of the American Society of Human Genetics, held from Nov. 1 to 5 in Washington, D.C.
COVID-linked loss of smell, taste found to resolve by 3 years after infection
There’s good news for folks who lost some of their sense of taste and smell after a bout of mild COVID: New research shows this side effect largely resolves by three years after infection.
Brain imaging identifies biomarkers of mental illness
Research and treatment of psychiatric disorders are stymied by a lack of biomarkers—objective biological or physiological markers that can help diagnose, track, predict, and treat diseases. In a new study, researchers use a very large dataset to identify predictive brain imaging-based biomarkers of mental illness in adolescents. The work appears in Biological Psychiatry.
Study suggests lower extremity lymphedema is a risk factor for multiple types of skin cancer
New research from Mayo Clinic finds that patients with lymphedema—swelling of the limbs caused by the accumulation of protein-rich fluids of the immune system—had twice the risk of developing skin cancer than patients without lymphedema.
Breast cancer prevention drug approved for post-menopausal women in the UK. Here’s how it works
A drug that can halve the risk of developing breast cancer in post-menopausal women has been approved for use in the UK. This drug, called anastrozole, could benefit an estimated 289,000 women in the UK who are at increased risk of breast cancer.
Do you think you have a penicillin allergy? You might be wrong
Antimicrobial resistance is one of the biggest global threats to health, food security and development. This month, The Conversation’s experts explore how we got here and the potential solutions.
Researchers decipher the mechanism by which the MAF protein promotes breast cancer metastasis
Breast cancer is the most common form of cancer among women, with more than 2 million new cases diagnosed each year. In cases where the tumor remains localized in the breast, survival rates are remarkably high, at around 90%. However, the spread of cancer cells beyond breast tissue and the formation of metastases in other organs dramatically worsens the prognosis and poses significant challenges.